Aurobindo Pharma Ltd Buyback
Aurobindo Pharma Buyback 2024
Tender Offer
₹1,460.00
Buyback price per share29 Jul, 2024
Last Date to buy shares30 Jul, 2024
Record Date05 Aug, 2024
Offer Opens09 Aug, 2024
Offer Closes09 Aug, 2024
Last Date for Tender Forms16 Aug, 2024
Finalisation of Buyback Acceptance19 Aug, 2024
Last Date for settlement of bids28 Aug, 2024
Last Date for Extinguishment of SharesAbout Aurobindo Pharma Ltd Buyback Company
Aurobindo Pharma is a manufacturer of active pharmaceutical ingredients (API) and formulation products in Pondicherry.
The company manufactures semi-synthetic penicillin (SSP), neuroscience (CNS), cardiovascular (CVS), antiretrovirals, antidiabetics, gastroenterology and antibiotics.
Aurobindo has a multi-product portfolio with manufacturing facilities in several countries. The company generated revenues of USD 2.6 billion in the financial year 2017-18. Aurobindo's 11 API/intermediates units and 15 formulations units (10 in India, 3 in the US, 1 in Brazil and 1 in Portugal) are designed to cater to the needs of both advanced and emerging markets.
Aurobindo Pharma Ltd Buyback Details
- Security Name Aurobindo Pharma Ltd
- Buyback Price ₹1,460.00
- Face Valuet ₹1.00
- Listing at Group BSE, NSE
- Lead Manager Axis Capital Limited
- Issue Size 51,36,986 ( 0.88% of Total number of equity Shares)
- Buyback Docs Letter Of Offer
Aurobindo Pharma Ltd Buyback Ratio
| Categoryy | Entitlement Ratio of Buyback | Shares Offered |
|---|---|---|
| Reserved Category for Small Shareholders | 5/41 | 770548 |
| General Category for all other Eligible Shareholders | 4/531 | 4366438 |
Aurobindo Pharma Ltd Buyback Company Financials
| 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Profit After Tax | 195.41 | 122.71 | -- |
| Total Assets | 2,515.40 | 2,505.88 | -- |
| Reserves And Surplus | -- | -- | -- |
| Net Worth | -- | -- | -- |
| Total Borrowing | -- | -- | -- |
| Total Revenue | 1,126.17 | 890.09 | -- |
How to Participate in Aurobindo Pharma Ltd Buyback?
Calculation of Investment in Aurobindo Pharma Ltd Buyback Buyback 2026
* No. of shares stands to change according to the closing price on the record date
* For simplicity, we have considered the price on date Jul 16, 2024
Expected Profit from the Aurobindo Pharma Ltd Buyback on the bases of acceptance Ratio:
| Acceptance Ratio | Amount Invested in Buyback | No. of Shares Buyback | Buyback Profit | Profit% |
|---|---|---|---|---|
| 33% | ₹187,815.07 | 45 | 4002 | 2.13% |
| 50% | ₹187,815.07 | 68 | 6048 | 3.22% |
| 75% | ₹187,815.07 | 102 | 9072 | 4.83% |
| 100% | ₹187,815.07 | 136 | 12097 | 6.44% |
Amount Invested in Buyback: ₹187,815.07
Aurobindo Pharma Ltd Buyback - Necessity of the Objective
The buy-back will help the company reward its shareholders and enhance the overall return to shareholders.
The buy-back is expected to improve earnings per share and other key ratios such as return on net worth and return on assets over a period of time.
The buy-back is being implemented through the tender offer route as prescribed under the buyback regulations and would involve the allocation of the number of equity shares as per their entitlement or 15% of the number of equity shares to be bought back, whichever is higher, reserved for small shareholders.
Contact Details
Aurobindo Pharma Ltd Buyback
Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032
+91 40 6672 5000
info@aurobindo.com
Registrar Contact Details
Kfin Technologies Limited
aurobindo.buyback@kfintech.com
04067162222, 04079611000